The breakage–fusion–bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma
Shamini Selvarajah(University Health Network), Maria Zieleńska(University of Toronto), Georges Maire(Centre National de la Recherche Scientifique), Jane Bayani(Ontario Institute for Cancer Research), Khaldoun Al‐Romaih(Ontario Institute for Cancer Research), Maisa Yoshimoto(University of Alberta), Paul C. Park, Jeremy A. Squire(Universidade de São Paulo), Gloria Lim(Hospital for Sick Children), Jana Paděrová(Ontario Institute for Cancer Research)
Cited by 57
Related Papers
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
|Annals of Oncology|2017|396
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
|Current Genomics|2008|293
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210